Delcath Systems, Inc. (DCTH)
NASDAQ: DCTH · Real-Time Price · USD
10.87
+0.20 (1.87%)
Sep 16, 2025, 2:27 PM EDT - Market open
Delcath Systems Market Cap
Delcath Systems has a market cap or net worth of $380.25 million as of September 16, 2025. Its market cap has increased by 27.64% in one year.
Market Cap
380.25M
Enterprise Value
298.49M
1-Year Change
27.64%
Ranking
Category
Stock Price
$10.87
Market Cap Chart
Since May 10, 2018, Delcath Systems's market cap has increased from $2.70M to $380.25M, an increase of 13,983.19%. That is a compound annual growth rate of 95.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 373.20M | -3.06% |
| Dec 31, 2024 | 385.00M | 319.85% |
| Dec 29, 2023 | 91.70M | 195.81% |
| Dec 30, 2022 | 31.00M | -45.61% |
| Dec 31, 2021 | 57.00M | -22.76% |
| Dec 31, 2020 | 73.80M | 9,125.00% |
| Dec 31, 2019 | 800.00K | -68.00% |
| Dec 31, 2018 | 2.50M | -7.41% |
| May 10, 2018 | 2.70M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 678.14B |
| Johnson & Johnson | 428.83B |
| AbbVie | 385.71B |
| UnitedHealth Group | 319.26B |
| AstraZeneca | 247.84B |
| Novo Nordisk | 242.99B |
| Novartis AG | 240.09B |
| Abbott Laboratories | 232.75B |